Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,934,843
-
Share change
-
-2,906,842
-
Total reported value
-
$18,936,992
-
Put/Call ratio
-
0%
-
Price per share
-
$0.95
-
Number of holders
-
41
-
Value change
-
-$2,850,098
-
Number of buys
-
12
-
Number of sells
-
21
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q2 2023
As of 30 Jun 2023,
AVROBIO INC - COM (AVRO) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,934,843 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, GMT CAPITAL CORP, ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, Aisling Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, BlackRock Inc., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.